Source: Pharmabiz

Regeneron: Fujifilm Diosynth Biotechnologies& Regeneron ink a 10year US manufacturing supply agreement valued at over $3 billion

Fujifilm Diosynth Biotechnologies, a world─leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, announced a 10─year manufacturing supply

Read full article »
Regeneron's Competitors | Regeneron's News | Regeneron's Financials
Stay up-to-date with the latest news on Regeneron
Annual Revenue
$10-50B
Employees
10-50K
Leonard S. Schleifer's photo - President & CEO of Regeneron

President & CEO

Leonard S. Schleifer

CEO Approval Rating

73/100

Read more
Stay up-to-date with the latest news on Regeneron